CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | Jin David Chief Financial Officer | Grant or award | +1,000,000 | 1,240,893 | ||
| 2024-10-01 | Jin David Chief Financial Officer | Grant or award | +2,625 | $1.23 | $3K | 240,893 |
| 2024-09-23 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Purchase | +763,359 | $1.84 | $1.4M | 3,657,264 |
| 2024-09-23 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Purchase · Warrants to Purchase Common Stock | +763,359 | $0.13 | $95K | 763,359 |
| 2024-07-11 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +5,000 | $7.48 | $37K | 127,500 |
| 2024-07-10 | Jin David Chief Financial Officer | Purchase | +500 | $7.50 | $4K | 500 |
| 2024-07-09 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +5,000 | $7.39 | $37K | 122,500 |
| 2024-07-08 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +5,000 | $7.35 | $37K | 117,500 |
| 2024-06-28 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +20,000 | $1.64 | $33K | 2,893,905 |
| 2024-05-20 | Klein Dov Director | Sale | −10,000 | $1.89 | $19K | 53,400 |
| 2024-05-16 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +10,000 | $1.76 | $18K | 2,873,905 |
| 2024-04-01 | Jin David Chief Financial Officer | Grant or award | +2,352 | $1.70 | $4K | 238,268 |
| 2024-01-05 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +50,000 | $2.38 | $119K | 2,863,905 |
| 2024-01-01 | Lu Lucy Director | Grant or award | +3,333 | 11,890 | ||
| 2024-01-01 | Lorenz Kevin Director | Grant or award | +3,333 | 24,304 | ||
| 2024-01-01 | LOBELL J JAY Director | Grant or award | +6,666 | 115,692 | ||
| 2024-01-01 | Klein Dov Director | Grant or award | +6,666 | 63,400 | ||
| 2024-01-01 | Hoenlein Malcolm Director | Grant or award | +3,333 | 39,042 | ||
| 2024-01-01 | Harvey Jimmie Director | Grant or award | +6,666 | 69,999 | ||
| 2024-01-01 | WEISS MICHAEL S See Remarks | Grant or award | +216,465 | 1,346,985 |
Page 2 of 6 · 105 trades